Redefining Relief: Emerging Innovations in the Management of Pulmonary Arterial Hypertension
Tuesday, August 20, 2024
Live Virtual Meeting
7:30 PM - 8:30 PM EASTERN
For full accreditation information and to register, click here or go to:
https://clinicaloptions.com/events/pulmonary-arterial-hypertension/pulmonary-arterial-hypertension/11336-13397
Faculty
Vallerie V. McLaughlin, MD
Kim A. Eagle, MD Endowed Professor of Cardiovascular Medicine
Interim Chief Clinical Officer, Ambulatory Care Services
Director, Pulmonary Hypertension Program
Michigan Medicine
Ann Arbor, Michigan
Learning Objectives
Upon completion of this activity, learners should be able to:
· Explain the pathophysiology, presentation, and risk of disease progression, emphasizing the role of early detection and diagnosis in enhancing patient outcomes
· Construct a guideline-directed, personalized initial treatment plan for a patient with PAH
· Outline evidence for emerging therapy approaches under investigation for management of PAH
